Julio Enrique Serrano Noguès
Direktor/Vorstandsmitglied bei INBEST PRIME II INMUEBLES SOCIMI, S.A.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ana Granado Lapuente | F | - | 7 Jahre | |
| Bernardo Bello Lafuente | M | - | 5 Jahre | |
| Jorge Betegón | M | - | - | |
| Ana María Pérez Durá | F | - | 5 Jahre | |
| Francisco Javier Basagoiti Miranda | M | - | 5 Jahre | |
| Carlos Bergnes de las Casas Gabarró | M | - | - | |
| Felipe de Oriol y Diaz de Bustamante | M | - | - | |
| José Luis de Juan Aracil Elejabeitia | M | - | - | |
| Philippe Clavel | M | 51 |
Curapath & Expansion of Drug Delivery Capabilities & Services
 Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | 1 Jahre |
| Jose Conejos | M | - |
Curapath & Expansion of Drug Delivery Capabilities & Services
Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | - |
| Jose Luis de Quesada Soriano | M | - | - | |
| Santiago Royo López | M | - | 5 Jahre | |
| Juan Bosco González del Valle Chávarri | M | - | 5 Jahre | |
| Elena Arrufat Diaz | F | - | 5 Jahre | |
| Pedro Alonso Agüera | M | - | - | |
| Elena Lis Ortega | F | - | 5 Jahre | |
| Jon Jessmer | M | - |
Curapath & Expansion of Drug Delivery Capabilities & Services
Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Rafael Fernando García-Tapia González-Camino | M | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Spanien | 18 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Julio Enrique Serrano Noguès
- Persönliches Netzwerk
